Trigger Point Injections for Migraine: Mechanism, Evidence, and Clinical Use

What Are Trigger Point Injections (TPIs)?

TPIs involve injecting a small volume of local anesthetic (lidocaine 1%, bupivacaine 0.25%), sometimes combined with corticosteroid, into myofascial trigger points—hyperirritable nodules in taut muscle bands that refer pain in predictable patterns.

Proposed Mechanisms in Migraine

  • Peripheral nociceptive input reduction: Anesthetic blocks afferent signaling from sensitized myofascial tissue to the trigeminocervical complex, lowering central sensitization drive.
  • Muscle relaxation: Mechanical disruption of taut bands + anesthetic effect reduces tonic muscle contraction, decreasing pericranial tenderness.
  • Descending modulation: May activate endogenous opioid and serotoninergic inhibitory pathways.
  • CGRP reduction: Local anesthetic may inhibit CGRP release from sensory nerve endings.

Evidence Base

  • RCTs: Small trials show TPIs (occipital, cervical, trapezius) reduce migraine frequency, intensity, and pericranial tenderness vs. sham or no treatment.
  • Systematic reviews: Moderate-quality evidence for short-term benefit in chronic migraine and tension-type headache; less clear for episodic migraine.
  • Best responders: Patients with prominent pericranial tenderness, cervicogenic component, or myofascial pain syndrome comorbidity.

Clinical Protocol

  • Assessment: Palpate for active trigger points (reproduces headache pattern, referred pain, local twitch response).
  • Common sites: Suboccipital, upper trapezius, sternocleidomastoid, temporalis, frontalis.
  • Technique: 1–2 mL 1% lidocaine per point; dry needling alternative. Ultrasound guidance for deep muscles.
  • Frequency: Weekly × 4–6, then monthly maintenance if beneficial.
  • Combination: Often paired with PT, posture correction, stress management.

Risks & Considerations

  • Minor: Bruising, soreness, vasovagal syncope.
  • Rare: Pneumothorax (supraclavicular), nerve injury, infection.
  • Not a standalone cure; adjunct to comprehensive migraine plan.
  • Contraindicated: Local infection, coagulopathy, allergy to anesthetic.

TPIs are a safe, minimally invasive option for migraine patients with identifiable myofascial drivers. They address the peripheral sensitization component that perpetuates central migraine pathophysiology. Best integrated within a multidisciplinary headache program.

Migraine - Related Articles